CERUS

cerus-logo

Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development.

#SimilarOrganizations #People #Financial #Website #More

CERUS

Social Links:

Industry:
Biotechnology Health Care Industrial Automation Manufacturing Smart Building

Founded:
1991-09-01

Address:
Concord, California, United States

Country:
United States

Website Url:
http://www.cerus.com

Total Employee:
51+

Status:
Active

Contact:
9252886001

Total Funding:
235.8 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Mobile Non Scaleable Content Sitelinks Search Box Euro


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

heartland-industries-logo

Heartland Industries

Heartland is a material innovation company that engineers hemp fibers as additives for plastics.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.


Current Advisors List

bj-cassin_image

B.J. Cassin Board Member @ Cerus
Board_member

not_available_image

William Rohn Member of the Board of Directors @ Cerus
Board_member

drew-pardoll_image

Drew Pardoll Member of the Advisory Board @ Cerus
Advisor

Current Employees Featured

laurence-m-corash_image

Laurence M. Corash
Laurence M. Corash SVP, CMO & CSO @ Cerus
SVP, CMO & CSO
2014-01-01

nina-mufti_image

Nina Mufti
Nina Mufti Vice President, Development and Red Blood Cell Program Leader @ Cerus
Vice President, Development and Red Blood Cell Program Leader
2013-01-01

william-m-greenman_image

William M. Greenman
William M. Greenman President and CEO @ Cerus
President and CEO

not_available_image

Carol Moore
Carol Moore VP Regulatory Affairs, Quality and Clinical @ Cerus
VP Regulatory Affairs, Quality and Clinical

kevin-d-green_image

Kevin D. Green
Kevin D. Green VP, Finance & CFO @ Cerus
VP, Finance & CFO
2014-01-01

not_available_image

Suzanne Margerum
Suzanne Margerum V.P. Development and Manufacturing @ Cerus
V.P. Development and Manufacturing

vivek-jayaraman_image

Vivek Jayaraman
Vivek Jayaraman Chief Operating Officer @ Cerus
Chief Operating Officer
2020-03-01

Founder


bj-cassin_image

B.J. Cassin

stephen-t-isaacs_image

Stephen T. Isaacs

Stock Details


Company's stock symbol is NASDAQ:CERS

Investors List

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Cerus

Official Site Inspections

http://www.cerus.com Semrush global rank: 3.59 M Semrush visits lastest month: 4.02 K

  • Host name: 121.126.237.35.bc.googleusercontent.com
  • IP address: 35.237.126.121
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Cerus"

Cerus Corporation - Investor Overview

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies …See details»

About Cerus - Cerus Corporate Site

About Cerus Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, …See details»

Cerus Corporation - Wikipedia

The Intercept Blood System for Platelets received EU CE MARK Class III certification in 2002, and US FDA pre-market approval on December 18, 2014. On March 10, 2016 the FDA granted an expanded modification on the existing approval to also treat platelets suspended in 100% plasma. In 2005 the platelet CE MARK was re-approved with a modification to extend platelet storage to seven days (previously five days). See details»

Careers - Cerus Corporate Site

About Cerus Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies …See details»

Cerus Corporation Announces Strategic Organizational …

Mar 2, 2020 “These promotions from within our senior leadership team are intended to create an organizational structure that is focused on the ownership of key deliverables, both commercially and across our development portfolio, …See details»

Cerus Corporation - Governance - Corporate Governance

Comprehensive Compliance Program. As part of Cerus Corporation’s continuing commitment to promote a culture of good corporate citizenship and responsibility, Cerus Corporation declares …See details»

Cerus - Crunchbase Company Profile & Funding

Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, …See details»

Cerus - Overview, News & Similar companies | ZoomInfo.com

View Cerus (www.cerus.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more. …See details»

Cerus Corporation | VentureRadar

Similar Companies: Utah Medical Products, Inc. USA Publicly Traded Utah Medical Products, Inc.® with particular interest in healthcare for women and their babies, develops, …See details»

Cerus Corporation Announces Strategic Organizational …

Mar 2, 2020 Cerus Corporation (Nasdaq:CERS) today announced the promotion of three key leaders within the Company in anticipation of the Company’s expected continSee details»

Mission and Values - Cerus Corporate Site

About Cerus Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, …See details»

Cerus Corporation - Cerus Corporation Announces Fourth Quarter …

Mar 5, 2024 Sequential Revenue Growth in the Fourth Quarter Driven by Sales in North America Narrowed GAAP Net Loss Attributable to Cerus Corporation to $1.3 Million for the Fourth …See details»

Cerus Corporation - Solid organization | Glassdoor

*mission driven, patient-centric *only organization that carries the Intercept product/no competitor in the US *culture of autonomy *the right people get promoted *most roles (non lab based) are …See details»

What is Cerus Corporation? Company Culture, Mission, Values

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. ... a notable deficiency in fostering a …See details»

Newsroom - Cerus Corporate Site

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, …See details»

Cerus Corporation - Cerus Corporation Announces Preliminary …

Jan 8, 2024 Cerus’ unaudited preliminary product revenue for the fourth quarter of 2023 totaled $46.8 million, representing an increase of 6% over the $44.0 million recognized during the …See details»

The Certus Group

The Certus Group. Founded by Managing Director, Steven Franzese, The Certus Group was created in response to “Big Box” style recruitment. With over 15 years of industry and …See details»

The Cerus Mission: a video - Cerus Corporate Site

About Cerus Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, …See details»

Cerus Corporation - Cerus Corporation Announces Contract with …

May 17, 2021 Canadian Blood Services first to implement pathogen inactivation technology in Canada Cerus Corporation (Nasdaq:CERS) today announced its contract with Canadian …See details»

linkstock.net © 2022. All rights reserved